Podcast
Questions and Answers
In Type 1 diabetes, dietary measures are the primary source of treatment.
In Type 1 diabetes, dietary measures are the primary source of treatment.
False (B)
Metformin is usually the first-line drug therapy for Type 2 diabetes.
Metformin is usually the first-line drug therapy for Type 2 diabetes.
True (A)
Long duration insulins have a distinct peak action.
Long duration insulins have a distinct peak action.
False (B)
Sliding scale dosing is used to adjust insulin doses based on blood sugar levels.
Sliding scale dosing is used to adjust insulin doses based on blood sugar levels.
Insulin needs are decreased during pregnancy.
Insulin needs are decreased during pregnancy.
Insulin pens are used for subcutaneous administration of insulin.
Insulin pens are used for subcutaneous administration of insulin.
Sitagliptin is a type of insulin that stimulates insulin release.
Sitagliptin is a type of insulin that stimulates insulin release.
Pramlintide is an oral medication used to treat Type 1 diabetes.
Pramlintide is an oral medication used to treat Type 1 diabetes.
Exenatide stimulates the pancreas to secrete insulin constantly, regardless of food intake.
Exenatide stimulates the pancreas to secrete insulin constantly, regardless of food intake.
Sitagliptin is known to cause hypoglycemia as a side effect.
Sitagliptin is known to cause hypoglycemia as a side effect.
Pramlintide is given to patients with Type 2 diabetes who are not taking an oral medication.
Pramlintide is given to patients with Type 2 diabetes who are not taking an oral medication.
Exenatide is used to treat Type 1 diabetes.
Exenatide is used to treat Type 1 diabetes.
Metformin can cause hypoglycemia.
Metformin can cause hypoglycemia.
Acarbose acts on the liver to reduce glucose production.
Acarbose acts on the liver to reduce glucose production.
Glyburide is a first-generation sulfonylurea.
Glyburide is a first-generation sulfonylurea.
Repaglinide stimulates insulin release and has a long duration of action.
Repaglinide stimulates insulin release and has a long duration of action.
Rosiglitazone is an alpha-glucosidase inhibitor.
Rosiglitazone is an alpha-glucosidase inhibitor.
Insulin needs are increased with decreased caloric intake and weight reduction.
Insulin needs are increased with decreased caloric intake and weight reduction.
